AbbVie: Stomach Neoplasms trials
The registry lists 10 Stomach Neoplasms studies with AbbVie as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 9Phase 2 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid TumorsRecruitingNCT07807956Phase 1
- Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab AdizutecanRecruitingNCT05005403Phase 1
- A Study of SC-007 in Subjects With Advanced CancerTerminatedNCT03253185Phase 1
- A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid TumorsCompletedNCT03071757Phase 1
- A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid TumorsCompletedNCT03000257Phase 1
- A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid TumorsCompletedNCT02033551Phase 1
- A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid TumorsCompletedNCT02009631Phase 1
- Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid TumorCompletedNCT01123876Phase 1
- huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction CarcinomasWithdrawnNCT00620607Phase 2
- Study of Motexafin Gadolinium and Docetaxel for Advanced CancerCompletedNCT00120939Phase 1